Search research articles
Contact Us
Filters
Showing results (291-300 of 420) with videos related to
Page
of 42
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 5, 2020
Assessment of Tedizolid <i>In Vitro</i> Activity and Resistance Mechanisms against a Collection of <i>Enterococcus</i> spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018
Cecilia G Carvalhaes, Helio S Sader, Robert K Flamm, et al.
Journal of Global Antimicrobial Resistance
|
November 21, 2018
Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America
Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program
Helio S Sader, Robert K Flamm, Jennifer M Streit, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
August 17, 2022
Antimicrobial Activity of Ceftaroline and Comparator Agents Against Ceftriaxone-Nonsusceptible <i>Streptococcus pneumoniae</i> from the United States (2008-2020)
Helio S Sader, Mariana Castanheira, Cecilia G Carvalhaes, et al.
BMC Pulmonary Medicine
|
January 25, 2025
Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022)
Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Antimicrobial Susceptibility of <i>Acinetobacter calcoaceticus-Acinetobacter baumannii</i> Complex and <i>Stenotrophomonas maltophilia</i> Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016)
Ana C Gales, Harald Seifert, Deniz Gur, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2011
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010
Rodrigo E Mendes, Leah N Woosley, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016)
Susanne Paukner, Steven P Gelone, S J Ryan Arends, et al.
Diagnostic Microbiology and Infectious Disease
|
March 13, 2013
An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011
Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Page
of 42
Search research articles
Search
Showing results (291-300 of 420) with videos related to
Sort By:
Page
of 42
Antimicrobial Agents and Chemotherapy
|
February 5, 2020
Assessment of Tedizolid <i>In Vitro</i> Activity and Resistance Mechanisms against a Collection of <i>Enterococcus</i> spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018
Cecilia G Carvalhaes, Helio S Sader, Robert K Flamm, et al.
Journal of Global Antimicrobial Resistance
|
November 21, 2018
Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America
Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program
Helio S Sader, Robert K Flamm, Jennifer M Streit, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
August 17, 2022
Antimicrobial Activity of Ceftaroline and Comparator Agents Against Ceftriaxone-Nonsusceptible <i>Streptococcus pneumoniae</i> from the United States (2008-2020)
Helio S Sader, Mariana Castanheira, Cecilia G Carvalhaes, et al.
BMC Pulmonary Medicine
|
January 25, 2025
Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022)
Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Antimicrobial Susceptibility of <i>Acinetobacter calcoaceticus-Acinetobacter baumannii</i> Complex and <i>Stenotrophomonas maltophilia</i> Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016)
Ana C Gales, Harald Seifert, Deniz Gur, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2011
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010
Rodrigo E Mendes, Leah N Woosley, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016)
Susanne Paukner, Steven P Gelone, S J Ryan Arends, et al.
Diagnostic Microbiology and Infectious Disease
|
March 13, 2013
An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011
Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Page
of 42